Overview: industrial perspectives on existing in vivo gene mutation assays.

A P Li, L D Kier
Author Information
  1. A P Li: Monsanto Company, St. Louis, Missouri 63167.

Abstract

In vivo gene mutation assays are considered the most definitive for the evaluation of human health risks. Suggestions are provided here for the critical evaluation of the application of established in vivo gene mutation assays and alternative approaches in the evaluation of industrial chemicals. Objective evaluation of the assays and approaches based on sound science and practical issues will allow better application of the existing assays. Such an evaluation may also help illuminate areas of improvement, as well as help guide the development of future assays.

MeSH Term

Animals
DNA Mutational Analysis
Industry
Mutagenicity Tests
Mutagens
Risk Factors

Chemicals

Mutagens

Word Cloud

Created with Highcharts 10.0.0assaysevaluationvivogenemutationapplicationapproachesindustrialexistinghelpconsidereddefinitivehumanhealthrisksSuggestionsprovidedcriticalestablishedalternativechemicalsObjectivebasedsoundsciencepracticalissueswillallowbettermayalsoilluminateareasimprovementwellguidedevelopmentfutureOverview:perspectives

Similar Articles

Cited By

No available data.